Springe direkt zu Inhalt

We acknowledge support and funding by the following organisations:

NanoMatFutur program of the Federal Ministry of Education and Research (BMBF)

Project: Mucin-derived peptides with mucolytic or antiviral properties (MucPep).

 

Collaborative Research Centre (CRC/SFB1449)

Project: Bioanalytics of complex biomaterials with advanced fluorescent probes.

 

Berlin University Alliance

Project: Antiviral peptides against SARS-CoV-2 (finished).

 

Federal Agency for Disruptive Innovation

Project: Antiviral spray against SARS-CoV2 - MucBoost.

 

SupraFAB

Project: Relevance of biological sex in influenza virus infection (BioSexSurf).

Project: Delivery of nucleic acids with mucin-based carrier systems (MucPlex).

 

Mukoviszidose e.V.

Project: Development of a FRET-based mucin assembly model (MucoFRET)